Surfactant replacement in preterm infants with respiratory distress syndrome

Surfactant replacement in preterm infants with respiratory distress syndrome

Authors

  • C. Dani

Keywords:

Surfactant, CPAP, respiratory distress syndrome, preterm infant

Abstract

Surfactant treatment has been demonstrated to decrease pneumothorax and mortality in preterm infants (with RDS). In many neonatal intensive care units NCPAP is used immediately after birth, while surfactant is given as early rescue in infants who develop RDS. This approach has been found safe and effective in several studies and a recent meta-analysis demonstrated a decreased risk of bronchopulmonary dysplasia or death in infants following this strategy.

Downloads

Published

01-07-2012

Issue

Vol. 83 No. 1 (2012): Supplement

Section

Session 2 – Exogenous surfactant in neonatology

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

1.
Dani C. Surfactant replacement in preterm infants with respiratory distress syndrome. Acta Biomed. 2012;83(1):19-22. Accessed February 24, 2025. https://mattioli1885journals.com/index.php/actabiomedica/article/view/2358